Target intelligence / Profile preview

Amyloid beta peptide aggregate

Molecular classification
Peptide aggregate, Protein aggregate
01

Overview

Amyloid beta (Aβ) peptide aggregates are assemblies of Aβ peptides, short fragments derived from the amyloid precursor protein (APP). These aggregates are central to Alzheimer’s disease pathology, accumulating as extracellular plaques and contributing to neurodegeneration. They exist in various forms, including oligomers, protofibrils, and fibrils, with oligomers being particularly neurotoxic. Therapeutic strategies focus on inhibiting aggregation, promoting clearance, and blocking toxic interactions with neuronal receptors.

Other names
Aβ aggregatesAmyloid plaquesAbeta oligomersAβ fibrilsAmyloid beta oligomersAmyloid beta fibrils
02

Mechanism of action

Inhibition of aggregation; promotion of clearance/degradation; blocking toxic interactions with neuronal receptors; reduction of Aβ production.

03

Biological functions

Synaptic dysfunctionNeurotoxicityCell membrane disruptionReceptor-mediated signaling
04

Disease associations

Alzheimer's diseaseNeurodegenerative disease
05

Safety considerations

Non-selective targeting of Aβ speciesOff-target effects of secretase inhibitorsInflammatory responses to anti-Aβ antibodiesARIA (Amyloid-Related Imaging Abnormalities)
06

Interacting drugs

Small molecules stabilizing non-toxic conformations

3 more in the full profile.

07

Biomarkers

Aβ40 levelsAβ42 levelsRatio of Aβ42/Aβ40Amyloid plaque burden (measured by PET imaging or CSF analysis)

Beyond the preview

Go deeper on Amyloid beta peptide aggregate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid beta peptide aggregate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call